1R,2S-N-CBZ-环己氨基醇 | 187333-96-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1R,2S-N-CBZ-环己氨基醇
• 中文别名: 氨甲酸,[(1R,2S)-2-羟基环己基]-,苯基甲基酯
• 英文名称: (1S,2R)-2-(benzyloxycarbonylamino)cyclohexan-1-ol
• 英文别名: benzyl (1R,2S)-N-(2-hydroxycyclohexyl)carbamate；benzyl (1S,2R)-N-(2-hydroxycyclohexyl)carbamate；(1R,2S-2-hydroxy-cyclohexyl)-carbamic acid benzyl ester；Carbamic acid, [(1R,2S)-2-hydroxycyclohexyl]-, phenylmethyl ester；benzyl N-[(1R,2S)-2-hydroxycyclohexyl]carbamate
• CAS: 187333-96-6
• 化学式: C₁₄H₁₉NO₃
• 分子量: 249.31
• InChiKey: IDQLGJJPYSFXPM-OLZOCXBDSA-N

物化性质

• 熔点：
  51-52 °C
• 沸点：
  427.6±44.0 °C(Predicted)
• 密度：
  1.17±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  58.6
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  甲酸铵 、 1R,2S-N-CBZ-环己氨基醇 在 palladium 10% on activated carbon 作用下， 以 四氢呋喃 、 乙醇 为溶剂， 反应 2.0h， 生成 (1S,2R)-2-amino-cyclohexan-1-ol formate
  参考文献：
  名称：

  [EN] NICOTINAMIDE DERIVATIVES USEFUL AS PDE4 INHIBITORS
  [FR] DERIVES DE NICOTINAMIDE AGISSANT COMME INHIBITEURS DE PDE4

  摘要：

  这项发明涉及式(I)的烟酰胺衍生物，以及含有该类衍生物的药物组合物，以及将这些衍生物用作PDE4抑制剂的用途，其中R7连接到苯环的3-或4-位，并且为S(O)pR8，R8为(C1-C4)烷基，可选择地被(C3-C6)环烷基取代；m为0或1；L为(C3-C8)非芳香环；其余变量如索权中所定义。

  公开号：

  WO2005009966A1
• 作为产物：
  描述：

  (2-氧代环己基)氨基甲酸叔丁酯 在 盐酸 、 氢氧化钾 、 trans-RuCl₂[(R)-xylbinap][(S)-daipen] 、 氢气 作用下， 以 乙醚 、 异丙醇 为溶剂， 25.0 ℃ 、810.65 kPa 条件下， 反应 29.0h， 生成 1R,2S-N-CBZ-环己氨基醇
  参考文献：
  名称：

  使用手性 RuCl2(二膦)(1,2-二胺) 配合物对氨基酮进行不对称氢化

  摘要：

  DOI：

  10.1021/ja001098k

文献信息

• Control of site-specific substitution of aminoglycosides by transition metal cations
  作者：Herbert A. Kirst、Brenda A. Truedell、John E. Toth

  DOI：10.1016/0040-4039(81)80079-2

  日期：1981.1

  The site of transition metal-directed acylations of apramycin and related aminoglycosides can be altered simply by changing the metal cation employed in the reaction.

  阿普霉素和相关氨基糖苷类的过渡金属导向的酰化位点可以通过改变反应中使用的金属阳离子来简单地改变。
• Dynamic Kinetic Resolution of 2-Oxocycloalkanecarbonitriles:  Chemoenzymatic Syntheses of Optically Active Cyclic <i>β</i>- and <i>γ</i>-Amino Alcohols
  作者：Juan R. Dehli、Vicente Gotor

  DOI：10.1021/jo0257288

  日期：2002.9.1

  Saccharomyces montanus CBS 6772 yielded the corresponding cis-hydroxy nitriles, 2, in >90% ee and de and in high chemical yields. Through simple and efficient procedures, they were transformed into optically active 2-amino and 2-aminomethyl cycloalkanols.

  已测试了一系列真菌和酵母对2-氧代环烷烃腈1的立体选择性生物还原的作用。酵母蒙塔纳酵母CBS 6772产生了相应的顺式羟基腈2，其ee和de大于90％，化学收率高。通过简单有效的方法，将它们转化为旋光的2-氨基和2-氨基甲基环烷醇。
• Enzymatic resolution of (±)-cis-2-aminocyclopentanol and (±)-cis-2-aminocyclohexanol
  作者：Amparo Luna、Covadonga Astorga、Ferenc Fülöp、Vicente Gotor

  DOI：10.1016/s0957-4166(98)00482-0

  日期：1998.12

  (+/-)-cis-N-Benzyloxycarbonyl-2-aminocyclopentanol was efficiently resolved by O-acylation with Pseudomonas cepacia lipase, as was (+/-)-cis-N-benzyloxycarbonyl-2-aminocyclohexanol when Candida antarctica lipase was used. (C) 1998 Elsevier Science Ltd. All rights reserved.

  (+/-)-cis-N-苯甲氧基羰基-2-氨基环戊醇通过恶臭假单胞菌酯酶催化的O-酰化反应得到了有效的光学分离；而(+/-)-cis-N-苯甲氧基羰基-2-氨基环己醇则在使用南极酵母酯酶时得到了分离。©1998 Elsevier Science Ltd. 保留所有权利。
• Nicotinamide derivatives useful as PDE4 inhibitors
  申请人：Bailey Simon

  公开号：US20050032838A1

  公开（公告）日：2005-02-10

  This invention relates to nicotinamide derivatives of formula (I) and to processes for the preparation of, intermediates used in the preparation of, pharmaceutical compositions containing, and the uses of such derivatives: wherein R 1 is selected from the group consisting of hydrogen, methyl or halo; R 7 is attached to the 3- or 4-position of the phenyl ring and is S(O) p R 8 , R 8 is (C 1 -C 4 )alkyl optionally substituted by (C 3 -C 6 )cycloalkyl; p is 0, 1 or 2; R 6 is selected from the group consisting of hydrogen, halo, (C 1 -C 3 )alkyl and (C 1 -C 3 )alkoxy; m is 0 or 1; L is a (C 3 -C 8 )carbocyclic non-aromatic ring; R 2 is hydrogen, hydroxy, (C 1 -C 3 )alkoxy, (C 1 -C 3 )alkyl (optionally substituted by hydroxy or by (C 1 -C 3 )alkoxy), CO 2 R 9 , NR 10 R 11 or CONR 10 R 11 ; R 3 is hydrogen or (C 1 -C 3 )alkyl; R 9 is hydrogen or (C 1 -C 3 )alkyl; R 10 and R 11 are each independently hydrogen, or, are selected from the group consisting of: (C 1 -C 6 )alkyl optionally substituted by phenyl or a 5- or 6-membered heterocyclic ring incorporating 1 to 3 heteroatom(s) independently selected from N, O and S, which phenyl is optionally substituted by one or more subsituents selected from hydroxy, halo, (C 1 -C 3 )alkyl or (C 1 -C 3 )alkoxy and which heterocyclic ring is optionally substituted by one or more subsituents selected from hydroxy, halo, (C 1 -C 3 )alkyl, (C 1 -C 3 )alkoxy or oxo; (C 3 -C 8 )cycloalkyl; CO((C 1 -C 6 )alkyl) optionally substituted by hydroxy, halo, (C 3 -C 8 )cycloalkyl, (C 1 -C 3 )alkoxy, phenyl or a 5- or 6-membered heterocyclic ring incorporating 1 to 3 heteroatom(s) independently selected from N, O and S, which phenyl is optionally substituted by one or more subsituents selected from hydroxy, halo, (C 1 -C 3 )alkyl or (C 1 -C 3 )alkoxy and which heterocyclic ring is optionally substituted by one or more subsituents selected from hydroxy, halo, (C 1 -C 3 )alkyl, (C 1 -C 3 )alkoxy or oxo; CO(R 12 ), wherein R 12 is (C 3 -C 8 )cycloalkyl optionally substituted by (C 1 -C 3 )alkyl or R 12 is phenyl or a 5- or 6-membered heterocyclic ring incorporating 1 to 3 heteroatom(s) independently selected from N, O and S, which phenyl is optionally substituted by one or more subsituents selected from hydroxy, halo, (C 1 -C 3 )alkyl or (C 1 -C 3 )alkoxy and which heterocyclic ring is optionally substituted by one or more subsituents selected from hydroxy, halo, (C 1 -C 3 )alkyl, (C 1 -C 3 )alkoxy or oxo; and CO 2 (C 1 -C 3 )alkyl); or R 10 and R 11 are taken together with the N atom to which they are attached to form a 5- or 6-membered lactam.

  本发明涉及化合物(I)的烟酰胺衍生物，以及制备这些衍生物的中间体的制备方法，含有这些衍生物的制药组合物，以及这些衍生物的用途：其中R1选自氢、甲基或卤素的群；R7附加到苯环的3-或4-位上，为S（O）pR8，R8为（C1-C4）烷基，可选地被（C3-C6）环烷基取代，p为0、1或2；R6选自氢、卤素、（C1-C3）烷基和（C1-C3）烷氧基的群；m为0或1；L为（C3-C8）非芳香环烷基；R2为氢、羟基、（C1-C3）烷氧基、（C1-C3）烷基（可选地被羟基或（C1-C3）烷氧基取代）、CO2R9、NR10R11或CONR10R11的群；R3为氢或（C1-C3）烷基；R9为氢或（C1-C3）烷基；R10和R11各自独立地选自以下群：（C1-C6）烷基，可选地被苯基或包含1至3个杂原子（独立选自N、O和S）的5-或6-成员杂环取代，其中苯基可选地被一个或多个亚基选自羟基、卤素、（C1-C3）烷基或（C1-C3）烷氧基，而杂环可选地被一个或多个亚基选自羟基、卤素、（C1-C3）烷基、（C1-C3）烷氧基或氧代基；（C3-C8）环烷基；CO（（C1-C6）烷基），可选地被羟基、卤素、（C3-C8）环烷基、（C1-C3）烷氧基、苯基或包含1至3个杂原子（独立选自N、O和S）的5-或6-成员杂环取代，其中苯基可选地被一个或多个亚基选自羟基、卤素、（C1-C3）烷基或（C1-C3）烷氧基，而杂环可选地被一个或多个亚基选自羟基、卤素、（C1-C3）烷基、（C1-C3）烷氧基或氧代基；CO（R12），其中R12为（C3-C8）环烷基，可选地被（C1-C3）烷基取代，或R12为苯基或包含1至3个杂原子（独立选自N、O和S）的5-或6-成员杂环，其中苯基可选地被一个或多个亚基选自羟基、卤素、（C1-C3）烷基或（C1-C3）烷氧基，而杂环可选地被一个或多个亚基选自羟基、卤素、（C1-C3）烷基、（C1-C3）烷氧基或氧代基；以及R10和R11一起与它们所附着的N原子形成5-或6-成员内酰胺。
• Alkyl 4-Chlorobenzoyloxycarbamates as Highly Effective Nitrogen Source Reagents for the Base-Free, Intermolecular Aminohydroxylation Reaction
  作者：Lawrence Harris、Simon P. H. Mee、Richard H. Furneaux、Graeme J. Gainsford、Andreas Luxenburger

  DOI：10.1021/jo1018816

  日期：2011.1.21

  Ethyl- (7), benzyl- (8), tert-butyl- (9), and fluorenylmethyl-4-chlorobenzoyloxycarbamates (10) have been prepared as storable and easy-to-prepare nitrogen sources for use in the intermolecular Sharpless aminohydroxylation reaction and its asymmetric variant. These reagents were found to be effective under base-free reaction conditions. The scope and limitations of these methods have been explored using a variety of alkenes, among which, trans-cinnamates, in particular, proved to be good substrates.